skip to main content
Close Icon

This website uses cookies. By continuing to use this site, you agree to our use of cookies. To find out more visit our Cookie Policy page.

Global Search Configuration

Refine Results

Clear All


Show More


Show More

Show More


Show More

Show More

895 Total results for product and free and sample content found


Merck KGaA Down-Plays Further Deals After Consumer Health Sell-Off

By John Davis 20 Apr 2018

The sale of the Merck KGaA consumer health business to Procter & Gamble could eventually give the German multinational greater flexibility in business development activities, but reducing net debt has first claim on the funds.

Topic Business strategies Company analysis


TVM Raises White Flag On Biovertis and Morphochem

By Mike Ward 20 Apr 2018

Denoive acquires from TVM Capital both Biovertis and Morphochem, plus a Phase II ready antibiotic asset, for an initial 4% stake worth €900,000. Since their formation, Biovertis and Morphochem have had more than $96m invested in them.

Topic Company analysis Business strategies

Datamonitor Healthcare

Datamonitor Healthcare Podcast 13 April 2018

15 Apr 2018

Zach McLellan, Jack Allen, and guest analyst Michael Ramirez discuss current events in the healthcare space in the Datamonitor Healthcare Analyst Podcast, including the Novartis purchase of AveXis for $8.7 billion as they target gene therapy in SMA.

Topic Company analysis


Biomedtracker 2018 Early Outlook Report

13 Apr 2018

What’s on the horizon for pharma in 2018? Find out with Biomedtracker’s Early 2018 Outlook Report extract. Download free extracts from this essential report, which investigates the catalysts expected to occur in the first part of the year for 21 different drugs.

Topic Drug development landscape

Medtrack, Datamonitor Healthcare

US overtakes Japan as top spot for regenerative medicines

By Jonathan Chan and Joji Sakurai 12 Apr 2018

The U.S. is set to usurp Japan's position as the global leader in regenerative medicine, a burgeoning field involving the creation of living cells to repair or replace human tissue ravaged by disease or genetic defects.


Pharmaprojects 2018 Pharma R&D Infographic

By Ian Lloyd 11 Apr 2018

Will the Pharma R&D Annual Review 2018 from Citeline’s Pharmaprojects be music to your ears, or will it sound a sour note? Find out with the Pharma R&D Annual Review 2018 infographic, now available to you as a free download.

Topic Drug development landscape


Pharma R&D Annual Review 2018 Supplement

By Ian Lloyd 10 Apr 2018

You’ve already tuned into Pharma R&D Annual Review 2018, the free, music-themed whitepaper from Citeline’s Pharmaprojects. Now, get even more free market data and insights with your download of Pharma R&D Annual Review 2018 Supplement: New Active Substances Launched During 2017.

Topic Drug development landscape

Datamonitor Healthcare

Datamonitor Healthcare Podcast 04 April 2018

By Jack Allen 09 Apr 2018

Zach McLellan & Jack Allen discuss current events in the healthcare space in the Datamonitor Healthcare Analyst Podcast, including analysis on Allogene's announcement that they are in-licensing the TALEN technology from Pfizer to commericalise and develop allogeneic, potentially leading to a strong acceleration of CART therapies.

Topic Drug development landscape

In Vivo

Winners Are Beginning To Emerge In Digital Health: But Without Planning Medtechs Risk Missing The Boat

By Ashley Yeo 08 Apr 2018

The leading medtechs are starting to develop models for providers that show how to implement successful digital strategies, a trend that is serving to put pressure on companies that are yet to make a commitment, says ZS Associates' Pete Masloski.

Topic Digital Health

Next steps

Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.

Request live demo now:

Our team is always happy to hear from you. Please call us at:

  • US Toll-Free  : +1 888 670 8900
  • US Toll           : +1 908 547 2200
  • UK & Europe : +44 (20) 337 73737
  • Australia        : +61 2 8705 6907
  • Japan              : +81 3 6273 4260

Or please submit your inquiry via the form so that we can provide you the best possible customer service.

Have an immediate and specific information need?

Browse and buy from 1000s of analysis and research reports now: